Adverse Drug Reactions and Toxicity

Adverse Drug Reactions and Toxicity

Adverse Drug Reactions and Toxicity

On this page

ADR Basics - What's the Harm?

  • Adverse Drug Reaction (ADR): Harmful, unintended effect of a drug at normal therapeutic doses (WHO definition).
  • Severity: Can range from Minor → Moderate → Severe → Lethal.
  • Classification (Rawlins & Thompson):
TypeFeature (Dose Dep.)Mnemonic (📌)Example(s)
AAugmented (Yes)ABCDEFDose-related toxicity
BBizarre (No)Allergy, Idiosyncrasy
CChronic (Yes/Time)Long-term use effects
DDelayed (Time)Carcinogenicity
EEnd-of-use (No)Withdrawal effects
FFailure (Varies)Resistance, Inefficacy

Type B (Bizarre) reactions are generally unpredictable, not dose-dependent, and often related to patient-specific factors like genetics (e.g., G6PD deficiency) or immune responses (e.g., penicillin allergy).

ADR Mechanisms - How Drugs Go Rogue

  • Type A (Augmented): Dose-dependent, predictable from known pharmacology. E.g., Bleeding with anticoagulants, severe hypoglycemia with insulin.
  • Type B (Bizarre): Dose-independent, unpredictable; often immune-mediated or due to genetic factors. E.g., Anaphylaxis to penicillin, G6PD deficiency hemolysis with primaquine.
  • Hypersensitivity Reactions (Gell & Coombs): Gell and Coombs Hypersensitivity Reactions Types I-IV
    TypeNameMediator(s)OnsetDrug Examples
    IAnaphylacticIgEMinutesPenicillin, NSAIDs
    IICytotoxicIgG, IgMVariableMethyldopa (hemolysis), Heparin (HIT)
    IIIImmune ComplexIgG, IgM1-3 wksSulphonamides, Penicillin (serum sickness)
    IVCell-MediatedT-cells2-3 daysAllopurinol (SJS/TEN), Topical neomycin

    ⭐ Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN) are severe Type IV reactions, often linked to allopurinol, lamotrigine, sulfonamides.

  • Other Types:
    • C (Chronic): Prolonged use (e.g., NSAID nephropathy).
    • D (Delayed): After stopping (e.g., tardive dyskinesia).
    • E (End-of-use): Withdrawal (e.g., opioid withdrawal).
    • F (Failure): Unexpected (e.g., antibiotic resistance).

Risk Factors & Susceptibility - Who's at Risk?

  • Patient-Specific:
    • Age extremes (neonates, elderly): altered pharmacokinetics (PK), ↓drug metabolism/excretion
    • Genetic factors: e.g., CYP polymorphisms (slow/rapid metabolizers), G6PD deficiency, HLA types (e.g., HLA-B*5701 & abacavir hypersensitivity)
    • Organ dysfunction: renal/hepatic impairment (↓drug clearance, ↑half-life)
    • Polypharmacy: ↑risk of drug-drug interactions (DDIs)
    • Physiological states: pregnancy, lactation (altered PK, fetal/neonatal risk)
    • History: previous ADRs, allergies, atopy
  • Drug-Specific:
    • Narrow therapeutic index (NTI): e.g., warfarin, digoxin, lithium, phenytoin, theophylline
    • Dose & duration: high doses, prolonged therapy
    • Properties: inherent toxicity, high allergenic potential (e.g., penicillins)

⭐ Patients with renal impairment are at significantly ↑risk for ADRs from drugs primarily excreted by kidneys (e.g., aminoglycosides, lithium, metformin, many NSAIDs).

Organ Toxicity & Teratogenicity - System Hit List

  • Organ-Specific Toxicity:

    OrganKey Drugs
    HepatotoxicParacetamol, Isoniazid, Halothane
    NephrotoxicAminoglycosides, NSAIDs, Cisplatin
    NeurotoxicVincristine (peri), Phenytoin (cereb)
    CardiotoxicDoxorubicin, Trastuzumab
    PulmotoxicAmiodarone, Bleomycin
    OtotoxicAminoglycosides, Furosemide
    Myelosupp.Chemotherapy, Chloramphenicol
  • Teratogenicity: Drug-induced fetal defects. Critical period: 3-8 weeks (organogenesis).

    • Thalidomide: Phocomelia 📌 Tha-limb-domide
    • Warfarin: Nasal hypoplasia, skeletal defects
    • Phenytoin: Fetal hydantoin syndrome
    • Valproate: Neural tube defects
    • ACE Inhibitors/ARBs: Renal dysplasia (2nd/3rd trimester)
    • Isotretinoin: CNS, craniofacial, CV defects
    • Lithium: Ebstein's anomaly

    ⭐ ACE inhibitors and ARBs are contraindicated in pregnancy, especially in the 2nd and 3rd trimesters, due to risks of fetal renal damage and oligohydramnios.

High‑Yield Points - ⚡ Biggest Takeaways

  • Type A ADRs are dose-dependent and predictable; Type B ADRs are non-dose-dependent and unpredictable.
  • Idiosyncratic reactions are genetically determined (e.g., G6PD deficiency with primaquine).
  • Teratogenicity involves drug-induced fetal malformations, with the first trimester being most critical.
  • CYP450 enzyme inducers (e.g., rifampicin) ↓ drug effect; inhibitors (e.g., ketoconazole) ↑ drug toxicity.
  • Key antidotes: N-acetylcysteine (paracetamol), naloxone (opioids), flumazenil (benzodiazepines).
  • Drug interactions (pharmacokinetic & pharmacodynamic) are a major source of ADRs and toxicity.
  • Therapeutic Drug Monitoring (TDM) is crucial for drugs with a narrow therapeutic index (e.g., digoxin, lithium).

Practice Questions: Adverse Drug Reactions and Toxicity

Test your understanding with these related questions

The risk of carbamazepine-induced Stevens-Johnson syndrome is increased in the presence of which of the following genes?

1 of 5

Flashcards: Adverse Drug Reactions and Toxicity

1/10

Examples of drugs eliminated by zero-order elimination include _____, ethanol, and aspirin (high concentrations)

TAP TO REVEAL ANSWER

Examples of drugs eliminated by zero-order elimination include _____, ethanol, and aspirin (high concentrations)

phenytoin

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial